This Hedge Fund Delivered a Solid Year. So Why Can’t Its Investors Cash Out?
Clients of Armistice Capital who recently redeemed got stuck with IOUs that have lost money in 2025.
This cheap, balanced portfolio will be a better investment than most hedge funds
As I’ve written repeatedly in recent months, the U.S. stock market is extremely overvalued, with an expected return over the ...
Hedge Funds Are Pocketing Much of Their Clients’ Gains With ‘No Limit’ Fees
A Bloomberg analysis of the major hedge funds’ regulatory filings shows their passthrough fees have exploded in recent years.
Anatomy of a deal: What goes into a $50 million hedge fund portfolio manager hire
The mechanics of a PM deal are complex. Contracts are increasingly nuanced and bespoke, including caveats and clawbacks.
Portfolio managers turned consultants and podcasters are demystifying what it's like to work at big-name hedge funds like Citadel or Point72
Multistrategy hedge funds are bigger than ever. Some who have worked for the biggest brands are now advising others on how to ...
Hedge fund Elliott commands attention in C-suites as relentless activist
When Elliott Investment Management buys into a company to agitate for change, bankers and lawyers who have faced the hedge ...
Trump's Sovereign Wealth Fund: What Is It And How Does It Work?
President Trump signed an executive order that puts in motion plans for a U.S. sovereign wealth fund. Here's what a sovereign ...
Hedge Fund Citadel Takes Short Position in GSK, FT Reports
Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, according to data from the Financial Conduct Authority, the FT report said.